US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services on Nov. 3 for "Live attenuated respiratory syncytial virus" (Maryland Inventors)

ALEXANDRIA, Va., Nov. 3 -- United States Patent no. 12,781,196, issued on Nov. 3, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.).

"Live attenuated respiratory syncytial virus" was invented by Peter Collins (Kensington, Md.) and Ursula Buchholz (Silver Spring, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Reported herein are novel recombinant respiratory syncytial viruses (RSV) having an attenuated phenotype. The recombinant RSV strains described here are suitable for use as live-attenuated RSV vaccines. Also provided are polynucleotide sequences capable of encoding the described viruses, as well as methods for produc...